S Kostense
Overview
Explore the profile of S Kostense including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bakker A, Python C, Kissling C, Pandya P, Marissen W, Brink M, et al.
Vaccine
. 2008 Sep;
26(47):5922-7.
PMID: 18804136
Immediate passive immune prophylaxis as part of rabies post-exposure prophylaxis (PEP) often cannot be provided due to limited availability of human or equine rabies immunoglobulin (HRIG and ERIG, respectively). We...
2.
Koldijk M, Bogaards J, Kostense S, de Vocht M, Gijsbers L, Ter Haak M, et al.
Vaccine
. 2007 Aug;
25(39-40):6872-81.
PMID: 17707954
Ensuring complete viral inactivation is critical for the safety of vaccines based on an inactivated virus. Detection of residual infectious virus is dependent on sensitivity of the assay, sample volume...
3.
van Baarle D, Hovenkamp E, Callan M, Wolthers K, Kostense S, Tan L, et al.
Blood
. 2001 Jun;
98(1):146-55.
PMID: 11418474
Acquired immunodeficiency syndrome-related non-Hodgkin lymphomas (AIDS-NHL) are thought to arise because of loss of Epstein-Barr Virus (EBV)-specific cellular immunity. Here, an investigation was done to determine whether cellular immunity to...
4.
Kostense S, Raaphorst F, Joling J, Notermans D, Prins J, Danner S, et al.
AIDS
. 2001 Jun;
15(9):1097-107.
PMID: 11416711
Objective: To evaluate dynamics in CD8 T cell expansions during highly active antiretroviral therapy (HAART). Design: Various T cell subsets were isolated from blood and lymph nodes and analysed for...
5.
Kostense S, Ogg G, Manting E, Gillespie G, Joling J, Vandenberghe K, et al.
Eur J Immunol
. 2001 Mar;
31(3):677-86.
PMID: 11241270
To investigate the effect of HIV-specific CD8(+) T cells on viral plasma load and disease progression, we enumerated HLA-A2-, B8- and B57-restricted CD8(+) T cells directed against several HIV epitopes...
6.
Kostense S, Krop E, Blaak H, Schuitemaker H, Miedema F
AIDS
. 2000 Mar;
14(3):330-1.
PMID: 10716514
No abstract available.
7.
Ogg G, Kostense S, Klein M, Jurriaans S, Hamann D, McMichael A, et al.
J Virol
. 1999 Oct;
73(11):9153-60.
PMID: 10516022
Few studies have examined longitudinal changes in human immunodeficiency virus type 1 (HIV)-specific cytotoxic T lymphocytes (CTL). To more closely define the natural history of HIV-specific CTL, we used HLA-peptide...
8.
Hamann D, Kostense S, Wolthers K, Otto S, Baars P, Miedema F, et al.
Int Immunol
. 1999 Jun;
11(7):1027-33.
PMID: 10383934
We recently showed that circulating human CD8(+) effector cells have a CD45RA+CD27(-) membrane phenotype. In itself this phenotype appeared to pose a paradox: CD45RA, a marker expressed by unprimed cells,...
9.
Kostense S, Raaphorst F, Notermans D, Joling J, Hooibrink B, Pakker N, et al.
AIDS
. 1999 Jan;
12(18):F235-40.
PMID: 9875570
Objectives: Highly active antiretroviral therapy (HAART) induces a decline in viral load and a biphasic increase in peripheral blood CD4+ T-cell counts in HIV-infected patients. To evaluate the effect of...
10.
Kostense S, Sun W, Cottey R, Taylor S, Harmeling S, Zander D, et al.
Antiviral Res
. 1998 Aug;
38(2):117-30.
PMID: 9707374
Interleukin 12 (IL-12) directs the differentiation of undifferentiated T helper (Th0) cells to T helper type 1 (Th1) cells and induces a cell-mediated immune response. To evaluate the effect of...